Astellas seeks US FDA approval for tacrolimus ER capsulespharmabiz.comAstellas Pharma US, Inc., a subsidiary of Tokyo-based Astellas Pharma Inc. has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) seeking approval fo…

ASTELLAS PHARMA : Astellas Submits U.S. New Drug Application for …4-tradersAstellas Submits U.S. New Drug Application for Tacrolimus Extended Release Capsules, a Prophylaxis of Organ Rejection in Transplant Recipients NORTHBROOK, IL. Sept., 24, 2012 …

Astellas seeks FDA approval for tacrolimus NDA for prophylaxis of organ rejectionNews-Medical.netAstellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), today announced it has submitted a Ne…

Novartis drug Votubia recommended by CHMP for EU approvalExpress PharmaThe Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for Votubia (everolimus) tablets for the treatment of adu…

Upsher-Smith Joins The National Eczema Association To Take Action During …Sacramento BeeSince topical corticosteroids are one of the most useful medications for treating eczema1, Upsher-Smith is taking action to help patients by offering the Trianex …

Boston Scientific Launches Drug Eluting Stent Solution to Treat Severe Lesions …StockhouseBoston Scientific has launched in European countries the PROMUS ELEMENT™ PLUS BTK (Below The Knee) Everolimus-Eluting Stent System for the treatment of certai…

AFPCuba develops its first industrial-scale nanopharmaceuticalDeccan HeraldExperts cited Saturday by local media said that the product was created by specialists at the Medicine Research and Development Center and is a "variation" of cyclospo…

EMA committee recommends approval of Novartis drug Votubia for non …pharmabiz.comNovartis has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for Votubia (ever…

AFPCuba launches first nanopharmaceuticalAFPHAVANA — Cuba has unveiled its first manufactured nanopharmaceutical drug — a tweaked variety of cyclosporine, used to help prevent transplant rejection — official media reported Saturday. "Its main …

Everolimus Reduces Breast Cancer Treatment Effects in BoneThe Oncology ReportAdding everolimus to exemestane for the treatment of estrogen receptor–positive advanced breast cancer that is refractory to nonsteroidal aromatase inhibitors has beneficial…